Top

BMC Cancer

Published in:

Open Access 01-12-2023 | Rectal Cancer | Research

Value of biplane transrectal ultrasonography plus micro-flow imaging in preoperative T staging and rectal cancer diagnosis in combination with CEA/CA199 and MRI

Authors: Qin Xia, Wei Cheng, Jie Bi, An-Ping Ren, Xiao Chen, Tao Li

Published in: BMC Cancer | Issue 1/2023

Abstract

Background

Rectal cancer is one of the most common malignant tumors and has a high incidence rate and fatality rate. Accurate preoperative T staging of rectal cancer is critical for the selection of appropriate rectal cancer treatment. Various pre-operative imaging methods are available, and the identification of the most accurate method for clinical use is essential for patient care. We investigated the value of biplane transrectal ultrasonography (TRUS) combined with MFI in preoperative staging of rectal cancer and explored the value of combining TRUS plus MFI with CEA/CA199 and MRI.

Methods

A total of 87 patients from Daping Hospital with rectal cancer who underwent TRUS examination plus MFI were included. Grades of MFI were determined by Alder classification. Among the total patients, 64 underwent MRI and serum CEA/CA199 tests additionally within one week of TRUS. Pathological results were used as the gold standard for cancer staging. Concordance rates between TRUS, MRI, and CEA/CA199 for tumors at different stages were compared.

Results

There were no significant differences between the Alder classification and pathological T staging. The concordance rate of TRUS and MFI for rectal cancer T staging was 72.4% (K = 0.615, p < 0.001). Serum CEA and CA199 levels were significantly different in tumors at different stages and increased progressively by pathological stage (p < 0.001); the accuracy rate was 71.88% (K = 0.599, p < 0.001), while that of MRI was 51.56% (K = 0.303, p < 0.001), indicating that TRUS had higher consistency in the preoperative T staging of rectal cancer. The combination of TRUS, MRI, and CEA/CA199 yielded an accuracy rate of 90.6%, which was higher than that of any method alone.

Conclusions

Preoperative T staging of rectal cancer from biplane TRUS plus MFI was highly consistent with postoperative pathological T staging. TRUS combined with MRI and serum CEA/CA199 had a greater value in the diagnosis of rectal cancer and a higher diagnostic rate than any examination alone.

Siegel RL, Miller KD, Fuchs HE, Jemal A, Cancer Statistics. 2021. CA Cancer J Clin. 2021;71(1):7–33. doi: 10.3322/caac.21654. Epub 2021 Jan 12. Erratum in: CA Cancer J Clin. 2021;71(4):359. PMID: 33433946.

Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020;17(7):414–29. https://doi.org/10.1038/s41575-020-0275-yCrossRefPubMed

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660CrossRefPubMed

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(7):874–901. https://doi.org/10.6004/jnccn.2018.0061CrossRefPubMedPubMedCentral

Skandarajah AR, Tjandra JJ. Preoperative loco-regional imaging in rectal cancer. ANZ J Surg. 2006;76(6):497–504. https://doi.org/10.1111/j.1445-2197.2006.03744.xCrossRefPubMed

Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol. 2007;17(2):379–89. https://doi.org/10.1007/s00330-006-0388-xCrossRefPubMed

Kim A, Lee CH, Kim BH, Lee J, Choi JW, Park YS, Kim KA, Park CM. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a defect on the hepatobiliary phase. Eur J Radiol. 2012;81(12):3998–4004. https://doi.org/10.1016/j.ejrad.2012.03.032CrossRefPubMed

Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the DISTANCE? Radiology. 2013;268(2):330–44. https://doi.org/10.1148/radiol.13121361CrossRefPubMed

Napoleon B, Pujol B, Berger F, Valette PJ, Gerard JP, Souquet JC. Accuracy of endosonography in the staging of rectal cancer treated by radiotherapy. Br J Surg. 1991;78(7):785–8. https://doi.org/10.1002/bjs.1800780707CrossRefPubMed

10.

de Koekkoek-Doll PK, Roberti S, van den Brekel MW, Maas M, Smit L, Beets-Tan R, Castelijns J. Value of assessing Peripheral vascularization with Micro-Flow Imaging, Resistive Index and Absent Hilum sign as Predictor for Malignancy in Lymph Nodes in Head and Neck squamous cell carcinoma. Cancers (Basel). 2021;13(20):5071. https://doi.org/10.3390/cancers13205071CrossRefPubMed

11.

Bacac M, Klein C, Umana P. CEA TCB: a novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors. Oncoimmunology. 2016;5(8):e1203498. https://doi.org/10.1080/2162402X.2016.1203498CrossRefPubMedPubMedCentral

12.

MacKenzie S, O’Dwyer PJ. Surveillance after colorectal cancer resection. Lancet. 2000;355(9209):1095.CrossRefPubMed

13.

Hao C, Sui Y, Li J, Shi Y, Zou Z. The clinical value of the combined detection of enhanced CT, MRI, CEA, and CA199 in the diagnosis of rectal Cancer. J Oncol. 2021;2021:8585371. https://doi.org/10.1155/2021/8585371CrossRefPubMedPubMedCentral

14.

Teng D, Wu K, Sun Y, Zhang M, Wang D, Wu J, Yin T, Gong W, Ding Y, Xiao W, Lu G, Li W. Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer. Oncotarget. 2018;9(16):12745–53. https://doi.org/10.18632/oncotarget.23993CrossRefPubMedPubMedCentral

15.

Reginelli A, Clemente A, Sangiovanni A, Nardone V, Selvaggi F, Sciaudone G, Ciardiello F, Martinelli E, Grassi R, Cappabianca S. Endorectal Ultrasound and magnetic resonance imaging for rectal Cancer staging: a Modern Multimodality Approach. J Clin Med. 2021;10(4):641. https://doi.org/10.3390/jcm10040641CrossRefPubMedPubMedCentral

16.

Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol. 1990;16(6):553–9. https://doi.org/10.1016/0301-5629(90)90020-dCrossRefPubMed

17.

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9. https://doi.org/10.3322/caac.21388CrossRefPubMed

18.

Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound. Dis Colon Rectum. 1985;28(1):42–6. https://doi.org/10.1007/BF02553906CrossRefPubMed

19.

Badea R, Gersak MM, Dudea SM, Graur F, Hajjar NA, Furcea L. Characterization and staging of rectal tumors: endoscopic ultrasound versus MRI / CT. Pictorial essay. Med Ultrason. 2015;17(2):241–7. https://doi.org/10.11152/mu.2013.2066.172.mriCrossRefPubMed

20.

Beynon J, Foy DM, Roe AM, Temple LN, Mortensen NJ. Endoluminal ultrasound in the assessment of local invasion in rectal cancer. Br J Surg. 1986;73(6):474–7. https://doi.org/10.1002/bjs.1800730618CrossRefPubMed

21.

Chan BPH, Patel R, Mbuagbaw L, Thabane L, Yaghoobi M. EUS versus magnetic resonance imaging in staging rectal adenocarcinoma: a diagnostic test accuracy meta-analysis. Gastrointest Endosc. 2019;90(2):196–203e1. https://doi.org/10.1016/j.gie.2019.04.217CrossRefPubMed

22.

Kav T, Bayraktar Y. How useful is rectal endosonography in the staging of rectal cancer? World J Gastroenterol. 2010;16(6):691–7. https://doi.org/10.3748/wjg.v16.i6.691CrossRefPubMedPubMedCentral

23.

Puli SR, Bechtold ML, Reddy JB, Choudhary A, Antillon MR, Brugge WR. How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review. Ann Surg Oncol. 2009;16(2):254–65. https://doi.org/10.1245/s10434-008-0231-5CrossRefPubMed

24.

Wang Y, Zhou CW, Hao YZ, Li L, Liu SM, Feng XL, Zhou ZX, Leung VY. Improvement in T-staging of rectal carcinoma: using a novel endorectal ultrasonography technique with sterile coupling gel filling the rectum. Ultrasound Med Biol. 2012;38(4):574–9. https://doi.org/10.1016/j.ultrasmedbio.2011.12.020CrossRefPubMed

25.

Yang H, Liu GJ, Lu MD, Xu HX, Xie XY. Evaluation of the vascular architecture of focal liver lesions using micro flow imaging. J Ultrasound Med. 2013;32(7):1157–71. https://doi.org/10.7863/ultra.32.7.1157CrossRefPubMed

26.

Han H, Ding H, Ji Z, Zhang W, Wang Q, Wang W. Primary application of Micro-Flow Imaging Technology in the diagnosis of hepatic tumors. Ultrasound Med Biol. 2019;45(2):395–401. https://doi.org/10.1016/j.ultrasmedbio.2018.09.025CrossRefPubMed

27.

Han H, Ji Z, Ding H, Zhang W, Zhang R, Wang W. Assessment of blood flow in the hepatic tumors using non-contrast micro flow imaging: initial experience. Clin Hemorheol Microcirc. 2019;73(2):307–16. https://doi.org/10.3233/CH-180532CrossRefPubMed

28.

Zhu L, Han P, Jiang B, Li N, Fei X. [Differential diagnosis of gallbladder polypoid lesions by micro-flow imaging]. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(6):922–8. https://doi.org/10.12122/j.issn.1673-4254.2022.06.17. Chinese.CrossRefPubMed

29.

Wang W, LIN N. Superb microvascular imaging in diagnosis of neovascularization in patients with carotid atherosclerotic plaque’ chinese. J Clin Res. 2019;32(01):65–7. https://doi.org/10.13429/j.cnki.cjcr.2019.01.016CrossRef

30.

Lin J, Lin W, Xu L, Lin T. Diagnostic value of various vascular features of breast cancer by age. Clin Hemorheol Microcirc. 2022;80(3):317–25. https://doi.org/10.3233/CH-211258CrossRefPubMed

31.

Cappelli C, Pirola I, Gandossi E, Marini F, Cristiano A, Casella C, Lombardi D, Agosti B, Ferlin A, Castellano M. Ultrasound Microvascular Blood Flow evaluation: a New Tool for the management of thyroid nodule? Int J Endocrinol. 2019;2019:7874890. https://doi.org/10.1155/2019/7874890CrossRefPubMedPubMedCentral

32.

García-Jiménez R, Arroyo E, Borrero C, Garcia-Mejido JA, Sosa F, Fernández-Palacín A, Sainz JA. Evaluation of placental micro-vascularization by superb micro-vascular imaging doppler in cases of intra-uterine growth restriction: a first step. Ultrasound Med Biol. 2021;47(6):1631–6. https://doi.org/10.1016/j.ultrasmedbio.2021.01.029CrossRefPubMed

33.

Hao C, Zhang G, Zhang L. Serum CEA levels in 49 different types of cancer and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:213–27. https://doi.org/10.1016/bs.pmbts.2018.12.011CrossRefPubMed

34.

Campos-da-Paz M, Dórea JG, Galdino AS, Lacava ZGM. De Fatima Menezes Almeida Santos M. Carcinoembryonic Antigen (CEA) and hepatic metastasis in Colorectal Cancer: update on Biomarker for Clinical and Biotechnological Approaches. Recent Pat Biotechnol. 2018;12(4):269–79. https://doi.org/10.2174/1872208312666180731104244CrossRefPubMed

35.

Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–27. https://doi.org/10.1200/JCO.2006.08.2644CrossRefPubMed

36.

Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology. 2004;232(3):773–83. https://doi.org/10.1148/radiol.2323031368CrossRefPubMed

37.

Lahaye MJ, Engelen SM, Nelemans PJ, Beets GL, van de Velde CJ, van Engelshoven JM, Beets-Tan RG. Imaging for predicting the risk factors–the circumferential resection margin and nodal disease–of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR. 2005;26(4):259–68. https://doi.org/10.1053/j.sult.2005.04.005CrossRefPubMed

38.

Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology. 2004;232(2):335–46. https://doi.org/10.1148/radiol.2322021326CrossRefPubMed

39.

Yu L, Wang L, Tan Y, Hu H, Shen L, Zheng S, Ding K, Zhang S, Yuan Y. Accuracy of magnetic resonance imaging in staging rectal Cancer with Multidisciplinary Team: a single-center experience. J Cancer. 2019;10(26):6594–8. https://doi.org/10.7150/jca.32685CrossRefPubMedPubMedCentral

40.

Rafaelsen SR, Sørensen T, Jakobsen A, Bisgaard C, Lindebjerg J. Transrectal ultrasonography and magnetic resonance imaging in the staging of rectal cancer. Effect of experience. Scand J Gastroenterol. 2008;43(4):440–6. https://doi.org/10.1080/00365520701745842CrossRefPubMed

41.

Harewood GC. Assessment of publication bias in the reporting of EUS performance in staging rectal cancer. Am J Gastroenterol. 2005;100(4):808–16. https://doi.org/10.1111/j.1572-0241.2005.41035.xCrossRefPubMed

42.

Baatrup G, Endreseth BH, Isaksen V, Kjellmo A, Tveit KM, Nesbakken A. Preoperative staging and treatment options in T1 rectal adenocarcinoma. Acta Oncol. 2009;48(3):328–42. https://doi.org/10.1080/02841860802657243CrossRefPubMed

43.

Bhutani MS. Recent developments in the role of endoscopic ultrasonography in diseases of the colon and rectum. Curr Opin Gastroenterol. 2007;23(1):67–73. https://doi.org/10.1097/MOG.0b013e328011630bCrossRefPubMed

44.

Winter L, Bruhn H, Langrehr J, Neuhaus P, Felix R, Hänninen LE. Magnetic resonance imaging in suspected rectal cancer: determining tumor localization, stage, and sphincter-saving resectability at 3-Tesla-sustained high resolution. Acta Radiol. 2007;48(4):379–87. https://doi.org/10.1080/02841850701196914CrossRefPubMed

45.

Fütterer JJ, Yakar D, Strijk SP, Barentsz JO. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence. Eur J Radiol. 2008;65(1):66–71. https://doi.org/10.1016/j.ejrad.2007.11.029CrossRefPubMed

46.

Sani F, Foresti M, Parmiggiani A, D’Andrea V, Manenti A, Amorotti C, Scotti R, Gallo E, Torricelli P. 3-T MRI with phased-array surface coil in the local staging of rectal cancer. Radiol Med. 2011;116(3):375–88. https://doi.org/10.1007/s11547-011-0621-1. English, Italian.CrossRefPubMed

47.

Loft MK, Pedersen MRV, Lindebjerg J, Rahr HB, Rafaelsen SR. Endorectal Ultrasound Shear-Wave Elastography of Complex rectal adenoma and early rectal Cancer. Diagnostics (Basel). 2022;12(9):2166. https://doi.org/10.3390/diagnostics12092166CrossRefPubMed

Title: Value of biplane transrectal ultrasonography plus micro-flow imaging in preoperative T staging and rectal cancer diagnosis in combination with CEA/CA199 and MRI
Authors: Qin Xia
Wei Cheng
Jie Bi
An-Ping Ren
Xiao Chen
Tao Li
Publication date: 01-12-2023
Publisher: BioMed Central
Keywords: Rectal Cancer
Rectal Cancer
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Published in: BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-023-11370-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2023

Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome

Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers

RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire

A simple and available measurement of onco-sEV dsDNA to protein ratio as a potential tumor marker

Keynote webinar | Spotlight on antibody–drug conjugates in cancer